methylprednisolone has been researched along with fr 180204 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maruki, R; Miyake, H; Nakajima, H; Ohori, M; Takeuchi, M | 1 |
1 other study(ies) available for methylprednisolone and fr 180204
Article | Year |
---|---|
FR180204, a novel and selective inhibitor of extracellular signal-regulated kinase, ameliorates collagen-induced arthritis in mice.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Collagen Type II; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Glucocorticoids; Hypersensitivity, Delayed; Immunoglobulin Isotypes; Injections, Intraperitoneal; Lymphocyte Activation; Male; Methylprednisolone; Mice; Mice, Inbred DBA; Pyrazoles; Pyridazines; T-Lymphocytes; Thymidine; Weight Loss | 2007 |